SUMMARY Two hundred twenty-nine hospital survivors of acute myocardial infarction (MI) age 60 years or younger underwent coronary arteriography a median of 2 weeks after infarction and were followed a median of 24 months (range 6-62 months). For 62%, MI was the first presentation of coronary disease and 75% were in clinical Killip class I. Overall outcome was good: 96% survival at 1 year and 95% survival at 2 years. This was due to the high prevalence of patients with one-vessel disease (58%), with a survival of 99% at 1 year and 96% at 2 years. Only 9% of patients had three-vessel disease and they had an 85% survival at 1 year. Eleven patients died and 23 had coronary bypass surgery. In this cohort of younger patients (mean age 51 years), prophylactic therapy may not be justified because of the low mortality and should be reserved for identifiable high-risk groups.
RECENT trials have suggested that ,3-adrenergic blocking drugs reduce mortality in survivors of myocardial infarction (MI),1-' as have previous trials with antiplatelet drugs. 4 The inference in these studies is that all patients who survive MI should be treated with an appropriate drug to reduce death rate. Before this axiom is translated into clinical practice, it is pertinent to reexamine the natural history of survivors of MI, which Kannel et al. 5 described as "inconsistent, fragmentary and inadequate." 5 The purpose of this study is to relate coronary anatomy -the number of arteries obstructed -to outcome in posthospital survivors of MI age 60 years and younger.
Methods

Patient Selection
From October 1976 to June 1981, 229 survivors of MI age 60 years or younger underwent coronary arteriography a median of 2 weeks (range 10 days to 16 weeks) after the onset of infarction and formed the study cohort. Patients gave informed consent for angiography and follow-up. Two hundred fifty-seven patients were eligible for the study and 229 (89%) underwent cardiac catheterization. The remaining 28 patients did not undergo coronary arteriography because they or their cardiologist did not consent to it. Patients younger than 60 years admitted initially to this hospital and who did not have other life-threatening disease were eligible for this study. Patients with cardiogenic shock and those who had previously undergone coronary bypass surgery were not eligible. Patients transferred from other hospitals were also excluded to avoid significant bias, as this hospital is a tertiary referral center, which receives many patients with complications of infarction. MI was diagnosed by the presence of two of the following criteria: a typical history of chest pain, the development of new pathologic Q waves on the ECG and a typical rise in serum CK enzyme, including a CK-MB fraction.
Cinical Data
Clinical data were collected prospectively on each patient and entered into a computerized information system. This consisted of a detailed history, daily physical examination throughout the hospital stay, chest x-ray and ECG.
Coronary arteriography and left ventriculography were performed by the Sones or Judkins technique in the right and left anterior oblique projections and read by two independent observers. Left ventricular ejection fraction (EF) was calculated for each patient using the area-length method.6 In the right, left anterior descending and circumflex arteries, narrowing of greater than 70% of luminal diameter in any projection agreed upon by two observers was considered significant. Left main disease (LMD) greater than 50% was considered significant. Only the most severe narrowing of each coronary artery was recorded, and patients were classified as having one-, two-or three-vessel disease. After discharge, patients were followed at 3-month intervals to a median of 24 months; the minimum follow-up time was 6 months. All patients were referred back to their physicians and no attempt was made to influence management. Probability of survival was estimated using Kaplan-Meier life tables, and log-rank analysis was used to compare survival between groups. Patients who underwent surgery remained in the analysis up to that time.
Results
Clinical Characteristics
The median age of the 229 patients was 51 years (range 27-60 years). One hundred ninety-five were males and 34 were females. Killip Classification and Electrocardiographic Variables (table 3) The number of patients with three-vessel disease increased with each Killip class (I, 6%; II, 15%; III, 25%) and the EF decreased. The distribution of one-, two-and three-vessel disease was not different in anterior and inferior infarction. The mean ejection fraction in anterior infarction was significantly lower than in inferior infarction. Similarly, when Q-wave and non-Q-wave infarcts were compared, the number of vessels involved was not different, but EF was lower in patients with Q-wave infarcts. In patients who developed ventricular tachycardia or fibrillation in the coronary care unit, the prevalence of three-vessel disease was higher and the EF lower than in those who did not have these arrhythmias.
Outcome
The median follow-up period was 24 months (range 6-62 months). There were 13 deaths, 1 Although prognosis in patients with angina pectoris has been related to coronary anatomy,7 8 few prospective studies are available relating coronary anatomy to prognosis after myocardial infarction. In our study, posthospital mortality is low, partly because of the high prevalence of one-vessel disease. This finding is Months in contrast to two reported studies.9' 10 Taylor et al.9 reviewed patients age 65 years or younger with > 50% stenosis. They did not mention whether transfer patients were included and only 39% of eligible patients underwent coronary arteriography, compared with 89% in our study. In the second prospective study, a similar percentage of eligible patients was studied, but those age 70 years or younger were included and transfers were not discussed. These two studies showed a prevalence of one-vessel disease of 26% and 23%, in contrast to 58% in our study; the prevalence of multivessel disease was 73% and 66.5%, in contrast to 35% in our study. The younger age of our patients, exclusion of referred patients, the fewer patients with previous infarction and the different definition of significant coronary artery obstruction may explain these differences.
In one study of 50 survivors of MI, 60% had multivessel disease but 80% were catheterized for angina, which was unstable in 66%.1" In another study of patients younger than 45 years who survived a first infarction, coronary arteriography done within 12 months showed that 64% had multivessel disease. Again, most of these patients were referred for study because they developed angina.'2 In a study with a 16% sudden death rate, at 1 year after infarction, 27% had suffered a previous MI and 12% cardiac failure.'3 As coronary arteriography has not been routinely performed on patients who are asymptomatic after infarction, these studies, like many other nonprospective studies, tend to be biased toward high-risk patients. This emphasizes the difficulties of retrospective analyses to define the natural history of myocardial infarction. In a prospective study of patients age 60 years or younger who underwent angiography after a second MI, the annual mortality was 3-4%, which agrees with our results. '4 Age is an important prognostic variable,", 16 and mortality increases exponentially beginning at age 55 years."' However, age was not as important in this study because patients older than 60 years were not included. The small but significant difference in outcome between the younger and older patients in this study were almost certainly due to differences in coronary anatomy. The Coronary Artery Surgery Study (CASS) in patients with chronic stable angina also emphasized the relationship between age and severity of coronary disease.'7 Sixty years of age was chosen as the upper age limit for our study because, when it began, coronary arteriography was not accepted as a usual procedure early after infarction in asymptomatic patients. In addition, we were interested in the out- come of patients who suffered complications of premature atherosclerosis. This group of patients represents a particular profile of early symptomatic presentation of coronary artery disease that has not been emphasized or appreciated previously. The mean age was low (51 years). Myocardial infarction was the first symptomatic presentation of coronary artery disease in 60% of all patients; 37% had a history of angina and only 11% previous infarction. This early presentation of coronary disease has a favorable outcome because of the high prevalence of one-vessel disease and good left ventricular function associated with first infarction. Much of the literature on the natural outcome of coronary artery disease is derived from referred patients with angina pectoris or retrospective analyses of patients who have suffered infarction. A community-based study, the Framingham survey5, showed that 50% of patients had myocardial infarction as the first symptom of coronary disease; the death rate was 5% at 1 year and 7% at 2 years. These figures are similar to those in our prospective study.
Inferior myocardial infarction is said to be associated with a high prevalence of multivessel disease, i.e., 64-80%. '819 In our study, inferior myocardial infarction was associated with 13% prevalence of three-vessel disease, 26% prevalence of two-vessel disease and 1-and 2-year survival of 98% and 96%. Similarly, non-Q wave infarction has been said to be associated with a high prevalence of multivessel disease and high mortality."' 20 Nearly 35% of our patients suffered non-Q wave infarction. This group had a 6% prevalence of three-vessel disease and a 26% prevalence of two-vessel disease; the 1-and 2-year survival rates were 100% and 98 ± 2%. Previous studies of non-Q wave and inferior infarction were not prospective and were biased because patients were usually referred for angiography for persistent angina, which suggests a more advanced type of coronary disease than seen in our series.
In our study, poor outcome was best predicted clinically by a history of MI and Killip class III. In both of these groups, the prevalence of three-vessel disease was increased and left ventricular EF was decreased. This is consistent with the data from the clinical indices used by Peel et al. 21 Norris et al. 22 and Killip and Kimball,23 which indirectly reflect both the severity of coronary artery obstruction and degree of left ventricular impairment. Few of our patients had suffered a previous MI or were in Killip class III, emphasizing that our group reflects the earlier presentation of coronary artery disease. EF is thought to be an independent prognostic factor after MI. Our data tend to suggest that a low EF only enhances mortality in association with two-or three-vessel disease, but not with onevessel disease; this finding has not been emphasized previously.
Apart from differences in age distribution, the cohort of survivors of MI in our series closely resembles the patient populations recruited for trials of secondary prevention.'-3 In the Norwegian Multicenter Trial of timolol,' exclusion criteria were similar to those used in our study, only 48% of patients surviving to 11 days being entered into the trial. In the Anturane Reinfarction study,4 only patients in Killip class I or II who had survived for 3 weeks after MI were entered. The placebo group in this trial had a mean age of 56 years and their 1-year survival was 93.5%.
The reported 1-year mortality in posthospital survivors of MI varies; 5% is commonly quoted.24 If subsets are considered, 1-year mortality varies from as high as 66% in patients with poor left ventricular function and ventricular dysrhythmia25 to as low as 1% in patients with one-vessel disease and good left ventricular function, as is shown in this study. These figures illustrate the complex heterogeneous population that may be included in a group of survivors of myocardial infarction. Of the 23 patients who had surgery in this group, many had severe multivessel obstruction, and outcome in this series may have been influenced by surgery, as 17 underwent surgery within 6 months of infarction. Most patients were operated on for symptoms, which is accepted management for patients with coronary artery disease. Surgery may influence outcome after infarction, although to what extent is not known.
Patients not operated on were followed by their physicians and no attempt was made to influence therapy. At some time during follow-up, 105 patients received (3-blocking agents. However, there was no difference in outcome between patients who received /3 blockers and those who did not.
In clinical practice, coronary arteriography is being done more often in younger survivors of MI, and it provided valuable prognostic information in this study. It is the only reliable means of accurately identifying the amount of coronary artery stenosis and at the same time assessing left ventricular function -the two major determinants of prognosis. High-risk subsets can be identified early after MI and managed by appropriate medical or surgical therapy. Trials of secondary prevention have shown significant differences in survival,'-3 and there is considerable pressure on physicians to treat all patients with /3 blockers after infarction. To recommend /3-blockade therapy for all patients after MI disregards the heterogeneous nature of this disease and presents a dilemma of inevitable medical therapy for very low risk subsets who do not require it or creates a false means of security for highrisk groups (i.e., left main disease patients who require operation rather than any medical therapy).
The present study suggests that when MI patients age 60 years or younger from the surrounding community are followed and treated by their physicians, 3-year survival is good because of the high prevalence of one-vessel disease. Prophylactic therapy may not be indicated for all.
